CMD begins project to revolutionise drug discovery using AI
The Centre for Medicines Discovery and King Abdulaziz University (KAU) have launched a major collaboration to accelerate medicines discovery using AI technologies, for diseases with unmet need, including rare diseases and cardio-metabolic diseases.
Read moreThe Centre for Medicines Discovery aims to catalyse the discovery and development of new medicines for patients.
LATEST PUBLICATIONS
-
The duration, dynamics and determinants of SARS-CoV-2 antibody responses in individual healthcare workers.
Journal article
Lumley SF. et al, (2021), Clin Infect Dis
-
Expression Screening of Human Integral Membrane Proteins Using BacMam.
Journal article
Mahajan P. et al, (2021), Methods Mol Biol, 2199, 95 - 115
-
The low-cost Shifter microscope stage transforms the speed and robustness of protein crystal harvesting.
Journal article
Wright ND. et al, (2021), Acta Crystallogr D Struct Biol, 77, 62 - 74
LATEST NEWS
Oxford ramps up COVID-19 testing capability
11 January 2021
The University of Oxford has joined forces with Thermo Fisher Scientific, the world leader in serving science, to ramp up the university’s capacity to deliver COVID-19 testing data.
Structure of the helicase core of Werner helicase, a key target in microsatellite instability cancers (new paper published)
17 December 2020
Loss of WRN, a DNA repair helicase, was identified as a strong vulnerability of microsatellite instable (MSI) cancers, making WRN a promising drug target.
TBXT: A new Target Enabling package for rare disease
20 November 2020
The Target Enabling Packages (TEPs) Programme continues to elucidate and enable novel targets for drug development.